A Comparison of Cetirizine, Ebastine, Epinastine, Fexofenadine, Terfenadine, and Loratadine versus Placebo in Suppressing the Cutaneous Response to Histamine
1999; Karger Publishers; Volume: 118; Issue: 2-4 Linguagem: Inglês
10.1159/000024126
ISSN1423-0097
AutoresJ. A. Grant, Linda Danielson, J.P. Rihoux, Christine DeVos,
Tópico(s)Drug-Induced Adverse Reactions
ResumoResearch Articles| April 23 1999 A Comparison of Cetirizine, Ebastine, Epinastine, Fexofenadine, Terfenadine, and Loratadine versus Placebo in Suppressing the Cutaneous Response to Histamine Subject Area: Immunology and Allergy J. Andrew Grant; J. Andrew Grant University of Texas Medical Branch, Galveston, Tex.,USA; Search for other works by this author on: This Site PubMed Google Scholar Linda Danielson; Linda Danielson UCB Pharma, Braine–l'Alleud, Belgium Search for other works by this author on: This Site PubMed Google Scholar Jean-Pierre Rihoux; Jean-Pierre Rihoux UCB Pharma, Braine–l'Alleud, Belgium Search for other works by this author on: This Site PubMed Google Scholar Christine DeVos Christine DeVos UCB Pharma, Braine–l'Alleud, Belgium Search for other works by this author on: This Site PubMed Google Scholar Int Arch Allergy Immunol (1999) 118 (2-4): 339–340. https://doi.org/10.1159/000024126 Article history Published Online: April 23 1999 Content Tools Views Icon Views Article contents Figures & tables Video Audio Supplementary Data Peer Review Share Icon Share Facebook Twitter LinkedIn MailTo Tools Icon Tools Get Permissions Cite Icon Cite Search Site Citation J. Andrew Grant, Linda Danielson, Jean-Pierre Rihoux, Christine DeVos; A Comparison of Cetirizine, Ebastine, Epinastine, Fexofenadine, Terfenadine, and Loratadine versus Placebo in Suppressing the Cutaneous Response to Histamine. Int Arch Allergy Immunol 1 April 1999; 118 (2-4): 339–340. https://doi.org/10.1159/000024126 Download citation file: Ris (Zotero) Reference Manager EasyBib Bookends Mendeley Papers EndNote RefWorks BibTex toolbar search Search Dropdown Menu toolbar search search input Search input auto suggest filter your search All ContentAll JournalsInternational Archives of Allergy and Immunology Search Advanced Search Keywords: Cetirizine, Ebastine, Epinastine, Fexofenadine, Histamine, Histamine H1 antagonists, Loratadine, Terfenadine, Skin tests 1999Copyright / Drug Dosage / DisclaimerCopyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed... 1999Copyright / Drug Dosage / DisclaimerCopyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements. You do not currently have access to this content.
Referência(s)